IVERIC bio Inc. Stock
IVERIC bio Inc. Stock
Our community identified positive and negative aspects for IVERIC bio Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the IVERIC bio Inc. stock. On the other hand our users think that "Management" could be a problem in the future.
Pros and Cons of IVERIC bio Inc. in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of IVERIC bio Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
IVERIC bio Inc. | - | - | - | - | - | - | - |
Jaguar Health Inc. | 22.310% | 7.947% | 53.774% | 4.220% | -46.026% | -99.976% | - |
Vaxart Inc. | 4.720% | 5.492% | 0.460% | 73.382% | 132.836% | -76.461% | - |
aTyr Pharma Inc | -0.570% | -3.352% | -4.420% | -3.648% | 34.109% | -56.750% | -72.479% |
Comments
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat